The Legal Examiner Mark The Legal Examiner Mark The Legal Examiner Mark search twitter facebook feed linkedin instagram google-plus avvo phone envelope checkmark mail-reply spinner error close
Skip to main content

A new lawsuit has been filed in relation to the dangerous side effects of Xarelto – a prescription blood thinner sold in America. The lawsuit joins more than 500 similar complaints currently pending in the Multidistrict Litigation (MDL No. 2592) in the U.S. District Court for the Eastern District of Louisiana.

A Wrongful Death Lawsuit

In this particular complaint, a widow from Missouri has filed a complaint against Janssen Research & Development, Johnson & Johnson and Bayer Healthcare – three companies involved in the manufacture and distribution of Xarelto in the U.S. – alleging that the negligence of these firms led to her husband’s wrongful death.

According to reports, the decedent was prescribed Xarelto in December of 2012 by his physician. He continued to use Xarelto until May 4th, 2013, at which point he was admitted to an intensive care unit where the hospital staff discontinued his use of the drug.

On May 22nd, 2013 the man died from an intracerebral hemorrhage which is a type of stroke caused by bleeding within the brain tissue.

The plaintiff in this case argues that her husband would not have taken Xarelto had he known about the risks associated with the drug.

She is suing to recover compensatory damages including medical expenses, loss of earnings, loss of companionship and funeral expenses incurred as a result of her husband’s use of Xarelto.

In addition to other allegations, the plaintiff claims that the defendants failed to warn the public about the dangers of certain Xarelto side effects and furthermore, intentionally hid information about risks associated with the drug.

Xarelto Lawsuits Being Filed Nationwide

Hundreds of Xarelto lawsuits have been filed across the country in relation to Xarelto after recently published studies linked the drug to dangerous side effects including uncontrollable internal bleeding.

“The number of cases in the Xarelto MDL is growing exponentially as we had anticipated,” noted Stephen A. Sheller, Esq. in response to the addition of this case.

“We are doing our best to inform people of their legal options with regard to the pending litigation and help those who wish to file a complaint,” Sheller continued.

Sheller is a sponsor of an which provides helpful resources and access to legal representation for those who may have been harmed by Xarelto.

Contact Information

Marc Goldich, Esq.

Comments are closed.